Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...
Mesa, Ariz.-based Tri-City Cardiology has added the CardioMEMS HF System following approval from CMS. The CardioMEMS system is a minimally invasive procedure that provides real-time monitoring of ...
ATLANTA, Aug. 26 -- CardioMEMS, Inc., a medical technology company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body, today ...
SPRINGFIELD, Mass. (WWLP) – Pioneer Valley Cardiology Associates at Mercy Medical Center has introduced the CardioMEMS Heart Failure Monitoring Program, a cutting-edge initiative to improve heart ...
MESA, Ariz., April 12, 2024 /PRNewswire/ -- In the ongoing battle against heart failure, continuous monitoring stands as a beacon of hope. Among the array of innovative solutions, the CardioMEMS™ HF ...
GAITHERSBURG, MD (updated) — A Food and Drug Administration (FDA) advisory committee narrowly voted in favor of a novel device that measures pulmonary-artery (PA) pressures in patients with heart ...
CardioMEMS, which develops wireless, implantable medical sensors, announced a new $37.9 million round of venture capital investment. That brings the company's total raised capital amount to about $145 ...
The first-of-its-kind TEAM-HF study seeks to improve clinical outcomes in patients with worsening heart failure Trial establishes new, objective criteria to identify patients most at risk for ...
Abbott Laboratories, Inc. ABT has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results